Publications by authors named "Hiroyuki Ochi"

Claim this Profile
H
Hachimijiogan, a traditional herbal medicine, modulates adipose cell function and ameliorates diet-induced obesity and insulin resistance in mice.
Syota Kagawa, Katsuya Tanabe, Makoto Hiromura, Kakuyou Ogawa, Takayuki Koga, Hiroyuki Ochi

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial.
Antonio González-Martín, Christophe Desauw, Florian Heitz, Claire Cropet, Piera Gargiulo, Hiroyuki Ochi

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential roles of the Wip1-p38-p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas.
Chenyang Xu, Takeo Minaguchi, Nan Qi, Kaoru Fujieda, Asami Suto, Hiroyuki Ochi

World J Surg Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian and non-ovarian teratomas: a wide spectrum of features.
Tsukasa Saida, Kensaku Mori, Tomohiko Masumoto, Sodai Hoshiai, Toshitaka Ishiguro, Hiroyuki Ochi

Jpn J Radiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clean intermittent catheterization on quality of life of patients with neurogenic lower urinary tract dysfunction due to radical hysterectomy: A cross-sectional study.
Noritoshi Sekido, Ei-Ichiro Takaoka, Hiroyuki Nishiyama, Hiroyuki Ochi, Toyomi Satoh

Low Urin Tract Symptoms· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.
Nobutaka Tasaka, Takeo Minaguchi, Yoshihiko Hosokawa, Wataru Takao, Hiroya Itagaki, Hiroyuki Ochi

J Obstet Gynaecol Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer.
Sari Nakao, Takeo Minaguchi, Hiroya Itagaki, Yoshihiko Hosokawa, Ayumi Shikama, Hiroyuki Ochi

J Ovarian Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report.
Narushi Iwata, Ayumi Shikama, Wataru Takao, Yoshihiko Hosokawa, Hiroya Itagaki, Hiroyuki Ochi

BMC Med Genet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.
Shuang Zhang, Takeo Minaguchi, Chenyang Xu, Nan Qi, Hiroya Itagaki, Hiroyuki Ochi

BMC Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma.
Azusa Akiyama, Takeo Minaguchi, Kaoru Fujieda, Yoshihiko Hosokawa, Keiko Nishida, Hiroyuki Ochi

Oncol Lett· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.
Ayumi Shikama, Takeo Minaguchi, Wataru Takao, Yoshihiko Hosokawa, Keiko Nishida, Hiroyuki Ochi

Int J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
Shou Ogawa, Makoto Suzuki, Hiroyuki Ochi, Mike Saji, Keitaro Mahara

Intern Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI Characteristics of Uterine Cervical Adenocarcinoma: Its Variants and Mimics.
Tsukasa Saida, Akiko Sakata, Yumiko Oishi Tanaka, Hiroyuki Ochi, Toshitaka Ishiguro

Korean J Radiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin.
Bouchra Lachkar, Takeo Minaguchi, Azusa Akiyama, Shuling Liu, Shuang Zhang, Hiroyuki Ochi

Medicine (Baltimore)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
Shuling Liu, Takeo Minaguchi, Bouchra Lachkar, Shuang Zhang, Chenyang Xu, Hiroyuki Ochi

PLoS One· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism.
Manabu Sakurai, Koji Matsumoto, Masahiko Gosho, Akiko Sakata, Yoshihiko Hosokawa, Hiroyuki Ochi

Int J Gynecol Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
Takeo Minaguchi, Toyomi Satoh, Koji Matsumoto, Manabu Sakurai, Hiroyuki Ochi

Int J Clin Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.
Ayumi Shikama, Takeo Minaguchi, Koji Matsumoto, Azusa Akiyama-Abe, Yuko Nakamura, Hiroyuki Ochi

Gynecol Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.
Mamiko Onuki, Koji Matsumoto, Manabu Sakurai, Hiroyuki Ochi, Takeo Minaguchi

J Gynecol Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Yuko Nakamura, Koji Matsumoto, Toyomi Satoh, Ken Nishide, Akiko Nozue, Hiroyuki Ochi

Int J Clin Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.
Manabu Sakurai, Toyomi Satoh, Koji Matsumoto, Hiroo Michikami, Yuko Nakamura, Hiroyuki Ochi

Int J Gynecol Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of dienogest on adenosarcoma arising from endometriosis: a case report.
Nobutaka Tasaka, Koji Matsumoto, Toyomi Satoh, Takeo Minaguchi, Mamiko Onuki, Hiroyuki Ochi

Springerplus· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.
Toyomi Satoh, Koji Matsumoto, Yumiko O Tanaka, Azusa Akiyama, Sari Nakao, Hiroyuki Ochi

Thromb Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac involvement of malignant lymphoma and its improvement after chemotherapy.
Hiroyuki Ochi, Takeshi Hozumi, Masashi Yamamoto, Masayuki Yamasaki, Hiroyuki Sugiyama

J Echocardiogr· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.
Azusa Abe, Takeo Minaguchi, Hiroyuki Ochi, Mamiko Onuki, Satoshi Okada

Hum Pathol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis